Diabetes
Conference Coverage
Weekly dulaglutide promising in youth with type 2 diabetes
“Considering that dulaglutide and the GLP-1 agonist class of drugs improve A1c [and] beta-cell function ... dulaglutide would provide a promising...
Conference Coverage
Tirzepatide powers ‘unprecedented’ weight loss in SURMOUNT-1
The twincretin tirzepatide produced jaw-dropping levels of weight loss in people with obesity and no diabetes compared with placebo in the...
Conference Coverage
Will tirzepatide slow kidney function decline in type 2 diabetes?
Compared to insulin glargine, tirzepatide was associated with significantly less new-onset macroalbuminuria in patients with T2D at high...
News
ADA 2022 preview: Tirzepatide and much more
Full SURMOUNT-1 data, new approaches to type 2 diabetes management, discoveries in type 1 diabetes prevention and treatment, disparities, mental...
News
ADA prioritizes heart failure in patients with diabetes
Patients with diabetes should have annual screening for biomarkers of early-stage heart failure, and treatment should prioritize an SGLT2...
News
FDA clears Abbott Freestyle Libre 3 glucose sensor
New features on the Freestyle Libre 3 system include real-time readings, improved accuracy, and smaller size.
News
SGLT2 inhibitors as first-line therapy in type 2 diabetes?
Real-world study finds heart failure hospitalization reduction, compared with metformin but not MI, stroke, or overall mortality and with greater...
News
Vitamin D doesn’t reduce type 2 diabetes risk ... or does it?
“Given how prevalent prediabetes and type 2 diabetes are, clinicians and patients should consider vitamin D supplementation as an adjunct to...
News
Experts endorse plant-based diet for type 2 diabetes remission
As a primary intervention, diet can achieve type 2 diabetes remission in many adults with normal or elevated BMI, and should be a plant-based,...
News
Newly approved tirzepatide’s retail price announced
The recently approved twincretin will carry a U.S. retail price similar to one of its main competitors, semaglutide, but patient discounts will be...